These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 23898909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Change characteristics of regional cerebral blood flow and curative efficacy in patients with obsessive-compulsive disorder].
    Wen SL, Yue JH, Cheng MF, Cheng MH.
    Zhonghua Yi Xue Za Zhi; 2012 Jul 17; 92(27):1896-900. PubMed ID: 23134961
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
    Diler RS, Kibar M, Avci A.
    Yonsei Med J; 2004 Feb 29; 45(1):90-9. PubMed ID: 15004874
    [Abstract] [Full Text] [Related]

  • 7. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Mohr N, Vythilingum B, Emsley RA, Stein DJ.
    Int Clin Psychopharmacol; 2002 Jan 29; 17(1):37-40. PubMed ID: 11800505
    [Abstract] [Full Text] [Related]

  • 8. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.
    Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, Marks IM, Ell PJ, Kerwin RW.
    Br J Psychiatry; 1995 Nov 29; 167(5):629-34. PubMed ID: 8564319
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
    Denys D, de Geus F, van Megen HJ, Westenberg HG.
    J Clin Psychiatry; 2004 Aug 29; 65(8):1040-8. PubMed ID: 15323587
    [Abstract] [Full Text] [Related]

  • 10. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.
    Mol Psychiatry; 2006 Jul 29; 11(7):622-32. PubMed ID: 16585942
    [Abstract] [Full Text] [Related]

  • 11. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.
    Kordon A, Wahl K, Koch N, Zurowski B, Anlauf M, Vielhaber K, Kahl KG, Broocks A, Voderholzer U, Hohagen F.
    J Clin Psychopharmacol; 2008 Oct 29; 28(5):550-4. PubMed ID: 18794652
    [Abstract] [Full Text] [Related]

  • 12. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study.
    Busatto GF, Buchpiguel CA, Zamignani DR, Garrido GE, Glabus MF, Rosario-Campos MC, Castro CC, Maia A, Rocha ET, McGuire PK, Miguel EC.
    J Am Acad Child Adolesc Psychiatry; 2001 Mar 29; 40(3):347-54. PubMed ID: 11288777
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
    Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ.
    J Clin Psychiatry; 2009 Jun 29; 70(6):863-8. PubMed ID: 19422759
    [Abstract] [Full Text] [Related]

  • 18. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment.
    Rubin RT, Ananth J, Villanueva-Meyer J, Trajmar PG, Mena I.
    Biol Psychiatry; 1995 Oct 01; 38(7):429-37. PubMed ID: 8672603
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
    Denys D, van Megen H, Westenberg H.
    J Clin Psychiatry; 2002 Aug 01; 63(8):700-3. PubMed ID: 12197450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.